As per a new study, millions of people should be given wonderdrugs, which include statins and fibrates, as they can slash the stroke risk by a third in the elderly.
Experts say there is clear evidence that even among the over-75s, a group not routinely prescribed cholesterol-busting statins, people can benefit from the life-saving drugs, the Daily Express reported.
Lead researcher Christophe Tzourio of the University of Bordeaux and Inserm said that one third reduction in stroke risk, if confirmed, could have an important effect on public health.
The research found the drugs are associated with a 30% lower stroke risk in healthy older adults, suggesting the drugs should now be considered for preventing stroke in older people as well.
The pills had traditionally been offered to people with a 20% risk of developing cardiovascular disease within 10 years, but the new advice said this threshold be lowered to include people with just a 10% risk.
The researchers concluded that their study results suggest that cholesterol lowering drugs could be considered for the prevention of stroke in older populations previously denied access to the drugs.
They wrote that their results raise the hypothesis of protection against stroke related to long term use of lipid (blood fat) lowering drugs for primary prevention in older people.
There have been suggestions that statins can cause worrying side effects, but experts have slammed claims of "over-medicalising" the nation insisting that the benefits of the drugs far outweigh the risks.
The study is published in The BMJ.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)